Focus: Verrica Pharmaceuticals is a specialty pharma company focused on topical therapies for dermatological and viral conditions, with a marketed product in molluscum contagiosum and warts and an emerging pipeline in basal cell carcinoma.
Profile data last refreshed 21m ago · AI intelligence enriched 2w ago
Stable — net +2 jobs in 30d
5 added, 3 removed. Backfill posture.
Best fit for early-career specialists willing to wear multiple hats in dermatology; unsuitable for those seeking large organization stability or diverse therapeutic exposure.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Verrica Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Verrica Pharmaceuticals's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
First-in-class topical cantharidin NDA with 17-year patent protection; sole marketed product driving near-term commercialization focus.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles